Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsNon-Current AssetsNon-Current Deferred Tax LiabilityNon-Current Deffered RevenueOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Cross Country Healthcare (CCRN) Accumulated Expenses (2016 - 2025)

Cross Country Healthcare (CCRN) has disclosed Accumulated Expenses for 16 consecutive years, with $41.9 million as the latest value for Q3 2025.

  • For the quarter ending Q3 2025, Accumulated Expenses changed N/A year-over-year to $41.9 million, compared with a TTM value of $41.9 million through Sep 2025, changed N/A, and an annual FY2024 reading of $47.6 million, down 8.89% over the prior year.
  • Accumulated Expenses was $41.9 million for Q3 2025 at Cross Country Healthcare, down from $45.3 million in the prior quarter.
  • Across five years, Accumulated Expenses topped out at $74.7 million in Q1 2022 and bottomed at $41.9 million in Q3 2025.
  • Average Accumulated Expenses over 5 years is $57.1 million, with a median of $54.1 million recorded in 2021.
  • The sharpest move saw Accumulated Expenses skyrocketed 84.52% in 2021, then decreased 27.97% in 2023.
  • Year by year, Accumulated Expenses stood at $65.6 million in 2021, then increased by 10.71% to $72.6 million in 2022, then dropped by 27.97% to $52.3 million in 2023, then fell by 8.89% to $47.6 million in 2024, then dropped by 12.15% to $41.9 million in 2025.
  • Business Quant data shows Accumulated Expenses for CCRN at $41.9 million in Q3 2025, $45.3 million in Q2 2025, and $50.1 million in Q1 2025.